Welcome to visit Zhongnan Medical Journal Press Series journal website!
Zhongnan Medical Journal Press
Series of Journals
Center for Evidence-Based and Translational Medicine of Wuhan University
The title
The title
The keywords
The author
Submit
Home
About us
Journal Introduction
Chief Editor
Editorial Committee
Author Center
Submission Guide
Assignment Agreement
Articles
Subscribe
Copyright
Contact us
Draft submission system
Author login
Author register
Reviewer login
Editor login
Home
Results
The title
The title
The keywords
The author
A total of
3
result was found. Results that relate to
Objective response rate
替雷利珠单抗联合索拉非尼治疗不可切除肝细胞性肝癌的疗效和安全性
JIANG Jinghua
HU Yiting
DOI:10.12173/j.issn.1008-049X.202406071
Tirilizumab
Sorafenib
Unresectable
Hepatocellular carcinoma
Objective response rate
Disease control rate
Progression-free survival
Overall survival
Details
Download
Mobile
他汀类药物对转移性肾细胞癌生存结局的影响
GAO Shiliang
HE Xiaoqi
ZHENG Huijie
YANG Di
YU Mingzhu
DOI:10.12173/j.issn.2097-4922.202406053
Metastatic renal cell carcinoma
Statins
Survival outcomes
Overall survival
Progression-free survival
Objective response rate
Disease control rate
Details
Download
Mobile
卡度尼利单抗联合贝伐珠单抗类似物与化疗治疗转移性结直肠癌的疗效评价及生存质量分析
ZHANG Xiaoqing
LIU Shuai
ZHANG Kai
HE Jing
WANG Yuchao
ZHANG Juan
LUAN Wei
DOI:10.12173/j.issn.2097-4922.202606069
Cadonilimab
Bevacizumab
Metastatic colorectal cancer
Efficacy evaluation
RAS-mutated
Progression-free survival
Objective response rate
Disease control rate
Details
Download
Mobile